Goldman Sachs’s Korro Bio KRRO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-20,944
| Closed | -$365K | – | 5265 |
|
2025
Q1 | $365K | Sell |
20,944
-2,357
| -10% | -$41K | ﹤0.01% | 4423 |
|
2024
Q4 | $887K | Buy |
23,301
+10,487
| +82% | +$399K | ﹤0.01% | 3986 |
|
2024
Q3 | $428K | Buy |
12,814
+3,823
| +43% | +$128K | ﹤0.01% | 4185 |
|
2024
Q2 | $305K | Sell |
8,991
-36,180
| -80% | -$1.23M | ﹤0.01% | 4208 |
|
2024
Q1 | $4.07M | Buy |
+45,171
| New | +$4.07M | ﹤0.01% | 2740 |
|
2023
Q4 | – | Sell |
-212,082
| Closed | -$78.5K | – | 4849 |
|
2023
Q3 | $78.5K | Buy |
+212,082
| New | +$78.5K | ﹤0.01% | 4432 |
|
2023
Q1 | – | Sell |
-42,925
| Closed | -$165K | – | 5190 |
|
2022
Q4 | $165K | Sell |
42,925
-13,040
| -23% | -$50.2K | ﹤0.01% | 4560 |
|
2022
Q3 | $100K | Sell |
55,965
-20,090
| -26% | -$35.9K | ﹤0.01% | 4917 |
|
2022
Q2 | $114K | Sell |
76,055
-87,453
| -53% | -$131K | ﹤0.01% | 5075 |
|
2022
Q1 | $346K | Buy |
163,508
+24,088
| +17% | +$51K | ﹤0.01% | 4817 |
|
2021
Q4 | $715K | Buy |
139,420
+3,728
| +3% | +$19.1K | ﹤0.01% | 4271 |
|
2021
Q3 | $958K | Buy |
135,692
+51,627
| +61% | +$364K | ﹤0.01% | 4006 |
|
2021
Q2 | $837K | Buy |
84,065
+57,966
| +222% | +$577K | ﹤0.01% | 4132 |
|
2021
Q1 | $248K | Sell |
26,099
-462
| -2% | -$4.39K | ﹤0.01% | 4734 |
|
2020
Q4 | $937K | Buy |
+26,561
| New | +$937K | ﹤0.01% | 3490 |
|
2020
Q3 | – | Sell |
-10,063
| Closed | -$234K | – | 4502 |
|
2020
Q2 | $234K | Buy |
+10,063
| New | +$234K | ﹤0.01% | 3926 |
|
2020
Q1 | – | Sell |
-17,607
| Closed | -$309K | – | 4486 |
|
2019
Q4 | $309K | Buy |
+17,607
| New | +$309K | ﹤0.01% | 3840 |
|